January 24, 2022Open Access

Endoscopic intermuscular dissection for deep submucosal invasive cancer in the rectum: a new endoscopic approach

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

EID for deep invasive T1 rectal cancer appears to be feasible and safe, and the high R0 resection rate creates the potential of rectal preserving therapy in 45 % of patients.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Moons et al. (Mon,) studied this question.

synapsesocial.com/papers/69da09372a25b240b7a3e150 https://doi.org/https://doi.org/10.1055/a-1748-8573

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Meta-analysis of oncological outcomes after local excision of pT1–2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery2016 · 87 citations
2Clinical outcomes of deep invasive submucosal colorectal cancer after ESD2017 · 54 citations
3Endoscopic full-thickness resection for early colorectal cancer2019 · 126 citations
4Systematic review and meta‐analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer2013 · 278 citations
5Peranal endoscopic myectomy (PAEM) for rectal lesions with severe fibrosis and exhibiting the muscle-retracting sign2018 · 43 citations

Me gusta

Guardar

Ver artículo completo